Learn More
ATCC Monocytes derived from; DYS0100 Induced; Pluripotent Stem Cell; Human (Homo sapiens)
Supplier: ATCC ACS7030
iPSC-derived Monocytes; DYS0100 are induced pluripotent stem cells that have been differentiated into CD14+ monocytes. These cells can be used in cancer immunology research, drug development, and toxicity screening.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.